- ICH GCP
- Registre des essais cliniques de l'UE
Page Nct des essais cliniques
Clinical Trial Results:
A phase III, randomised, double-blind, three-arm, placebo-controlled, multi-center study to evaluate the safety and efficacy of oral Cladribine in subjects with relapsing remitting multiple sclerosis
Summary | |
EudraCT number | 2004-005148-28 |
Trial protocol | FI GB DK EE CZ BE IT AT SK LT DE LV |
Global completion date | 19 Dec 2008 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 24 Jun 2016 |
First version publication date | 24 Jun 2016 |
Other versions | |
Summary report(s) | 2004-005148-28_CT.gov results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.